4//SEC Filing
HELLUMS RHONDA LYNETTE 4
Accession 0001415889-25-000744
CIK 0001479615other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:15 PM ET
Size
5.6 KB
Accession
0001415889-25-000744
Insider Transaction Report
Form 4
HELLUMS RHONDA LYNETTE
DirectorChief Financial Officer
Transactions
- Award
Employee Share Option (Right to Buy)
2025-01-02+375,000→ 375,000 totalExercise: $2.40Exp: 2035-01-02→ Ordinary Shares (375,000 underlying)
Footnotes (1)
- [F1]One fourth (1/4th) of the shares subject to the option shall vest on January 2, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.
Documents
Issuer
Silence Therapeutics plc
CIK 0001479615
Entity typeother
Related Parties
1- filerCIK 0001766456
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:15 PM ET
- Size
- 5.6 KB